Praxis Precision Medicines (PRAX) Operating Leases (2022 - 2024)
Historic Operating Leases for Praxis Precision Medicines (PRAX) over the last 3 years, with Q4 2024 value amounting to $110000.0.
- Praxis Precision Medicines' Operating Leases fell 9559.12% to $110000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $110000.0, marking a year-over-year decrease of 9559.12%. This contributed to the annual value of $110000.0 for FY2024, which is 9559.12% down from last year.
- Per Praxis Precision Medicines' latest filing, its Operating Leases stood at $110000.0 for Q4 2024, which was down 9559.12% from $436000.0 recorded in Q3 2024.
- Praxis Precision Medicines' 5-year Operating Leases high stood at $3.5 million for Q4 2022, and its period low was $110000.0 during Q4 2024.
- Its 3-year average for Operating Leases is $1.9 million, with a median of $2.1 million in 2023.
- In the last 5 years, Praxis Precision Medicines' Operating Leases crashed by 2871.43% in 2023 and then tumbled by 9559.12% in 2024.
- Quarter analysis of 3 years shows Praxis Precision Medicines' Operating Leases stood at $3.5 million in 2022, then fell by 28.71% to $2.5 million in 2023, then tumbled by 95.59% to $110000.0 in 2024.
- Its Operating Leases stands at $110000.0 for Q4 2024, versus $436000.0 for Q3 2024 and $755000.0 for Q2 2024.